Fig. 6From: Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum The mechanism of invasion inhibition is unlikely to target the apicoplast ribosome. (a) Clindamycin targets the same subunit of the apicoplast ribosome but was found to have a much higher IC80 for apparent merozoite invasion inhibition (2,972 μM). There was evidence of non-specific inhibition of invasion as pretreatment of erythrocytes with clindamycin gave significant inhibition, which was not seen for azithromycin (prepared in ethanol; mean and SEM of four or more experiments; significance of differences tested with an unpaired t-test; **P ≤0.01) (38 μM). (b) The D10-AZRr line showed up to a 57-fold higher tolerance of azithromycin in 2 cycle (delayed death) apicoplast-targeting drug inhibition assays compared to D10 parental line. In contrast, the IC50 for purified merozoite invasion inhibitory activity differed by less than 2.5-fold between the D10-AZRr line and the D10-PfPHG line for (c) azithromycin (IC50: PfPHG 10 μM; D10-AZRr 25 μM), (d) erythromycin A (IC50: PfPHG 420 μM; D10-AZRr 732 μM) and (e) clindamycin (IC50: PfPHG 743 μM; D10-AZRr 557 μM). Data represent the mean of two or more experiments in at least duplicate. D10-AZRr, D10 azithromycin-resistantBack to article page